You are here

5 - Pre-clinical

Novel TCR for the Treatment of Nasopharyngeal Carcinoma

We are seeking a partner experienced in the field of cell therapy development and in the Chinese regulatory environment to take this technology through to first in man trials in China. The technology demonstrates in vivo efficacy with no observed toxicities. Cancer Research UK is prosecuting a patent for the technology and the relevant sequences.

Subscribe to RSS - 5 - Pre-clinical